Nonalcoholic fatty liver disease may cause thrombocytopenia

Acta Haematologica

Volumn 132, Issue 2, 2014, Pages 159-162

  Ruiz Argüelles, Guillermo J ^a,b,c,d   Velazquez Sanchez De Cima, Sara ^a,c   Zamora Ortiz, Gabriela ^a,d   Hernandez Reyes, Jesús ^a,e   Ruiz Delgado, Guillermo J ^a,b,d  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c UNIVERSIDAD POPULAR AUTÓNOMA DEL ESTADO DE PUEBLA   (Mexico)

^d UNIVERSIDAD DE LAS AMÉRICAS PUEBLA   (Mexico)

^e UNIVERSIDAD DEL VALLE DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; ANTINUCLEAR ANTIBODY; APOLIPOPROTEIN A; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOCHEMICAL MARKER; CHOLESTEROL; CYANOCOBALAMIN; ERYTHROPOIETIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HAPTOGLOBIN; PHOSPHOLIPID ANTIBODY; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID; PLASMA PROTEIN; THROMBOPOIETIN;

ACUTE LIVER FAILURE; ADULT; AGED; ANTIBODY TITER; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CYTOPENIA; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEREDITY; HIV TEST; HUMAN; HYPERSPLENISM; INFLAMMATION; INFORMED CONSENT; INSULIN RESISTANCE; KIDNEY FUNCTION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST KIT; LIVER INJURY; MALE; MEGAKARYOCYTE; METABOLIC SYNDROME X; MOLECULAR MECHANICS; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PANCYTOPENIA; PHYSICAL EXAMINATION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; VIRUS HEPATITIS; HEPATOMEGALY; BLOOD; FATTY LIVER; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

AGED; BILIRUBIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PROTEINS; FATTY LIVER; FEMALE; HUMANS; LIPIDS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PLATELET COUNT; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 84895666987     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000357934     Document Type: Article

References (11)

1. Ibrahim MA, Kelleni M, Geddawy A: Nonalcoholic fatty liver disease: Current and potential therapies. Life Sci 2013; 92: 114-118.
2. Mawatari H, Yoneda M, Kirikoshi H, Maeda S, Nakajima A, Saito S: Thrombocytopenia is more severe in patients with chronic hepatitis C than in patients with nonalcoholic fatty liver disease. J Gastroenterol 2012; 47: 606-607.
3. Dasanu CA, Lamana S, Trikudanathan G: Thrombocytopenia, NAFLD, and metabolic syndrome: Is there a link? South Med J 2010; 103: 1071.
4. Dasanu CA, Lamana S, Trikudanathan G: Thrombocytopenia in NAFLD: Is thrombopoietin involved? South Med J 2010; 103: 1278-1279.
5. Morra R, Munteanu M, Imbert-Bismut F, Messous D, Ratziu V, Poynard T: FibroMAX: Towards a new universal biomarker of liver disease? Expert Rev Mol Diagn 2007; 7: 481-490.
6. Festi D, Schiumerini R, Marzi L, Di Biase AR, Mandolesi D, Montrone L, Scaioli E, Bonato G, Marchesini-Reggiani G, Colecchia A: Review article: The diagnosis of non-Alcoholic fatty liver disease. Aliment Pharmacol Ther 2013; 37: 392-400.
7. Arnold DM: Immune thrombocytopenia: Getting back to basics. Am J Hematol 2012; 87: 841-842.
8. Medina-Santillán R, López-Velázquez JA, Chávez-Tapia N, Torres-Villalobos G, Uribe M, Méndez- Sánchez N: Hepatic manifestations of metabolic syndrome. Diabetes Metab Res Rev 2013, Epub ahead of print.
9. Torre-López E, Salazar-Pachicano J: Anemias secundarias a padecimientos no hematológicos; in Ruiz-Argüelles GJ (ed): Fundamentos de Hematología, ed 4. México City, Editorial Médica Panamericana, 2009, pp 129-142.
10. Hernández-Reyes J, Ruiz-Argüelles GJ, Velázquez- Sánchez-de-Cima S, Zamora-Ortiz G, Ruiz-Delgado G: The thrombocytopenia of nonalcoholic fatty liver disease. Rev Hematol Méx 2013; 14(suppl 2):S40.
11. Freni MA, Spadaro A, Ajello A, Barbaro E, Scaffidi M, Alessi N, Resta ML, Ferrau O: Serum thrombopoeitin in chronic liver disease; relation to severity of the disease and spleen size. Hepatogastroenterology 2002; 49: 1382-1385.